Thank you to all that attended. To access a full recap of this archived meeting, please Click HERE. BIOPHARMA CONGRESS III November 14, 2017 Disruption In Biopharma The Ritz-Carlton, Washington D.C. 1150 22nd Street, NW PRESENTED BY FRIENDS OF CANCER RESEARCH + PREVISION POLICY DRUG PRICING. APPROVAL STANDARDS. THE FUTURE FDA. MEDICARE PART B &…
June 27, 2017, 10am – 4:30pm JW Marriott Washington, DC 10:00am – 10:15am Welcome Kim Thiboldeaux, CEO, Cancer Support Community 10:15am – 10:30am Patient Perspective Introduction: Patricia Goldsmith, CEO, CancerCare Patient remarks- Marin Mazzie 10:30am – 10:50am Keynote Greg Simon, Executive Director, Biden Cancer Initiative 10:50am – 11:30am Blue Ribbon Panel Update Report Doug Lowy,…
Thank you to all that attended our 2016 Annual Meeting! Click HERE to access the meeting report, including issue briefs from each panel. Panel Slides from our meeting can be accessed below: Panel 1 Slides Panel 2 Slides Panel 3 Slides Wednesday, November 16 8:30 am – 4 pm Hyatt Regency Washington on Capitol Hill…
Election Impact On Biopharma in 2017 November 4, 2016 Ritz-Carlton Washington, DC 1150 22nd Street, NW On Friday, November 4, 2016, Friends of Cancer Research (Friends) and Prevision Policy convened the second annual BioPharma Congress. This year’s event focused on the impact of the presidential election on biopharma in 2017 and featured speakers such as…
On May 24, 2016, Friends cohosted the 2016 Immuno-Oncology Clinical and Patient Roundtable with the Alliance for Regenerative Medicine. This roundtable consisted of experts in the field of immuno-oncology and regulatory health policy, as well as patients. Panelists came from diverse backgrounds, including academia, industry, and government. The event aimed to educate and inform major…
On November 10, 2011, Friends of Cancer Research (Friends) and the Engelberg Center for Healthcare Reform at Brookings co-hosted the fourth-annual Conference on Clinical Cancer Research, with the support of The American Society of Clinical Oncology (ASCO), and Susan G. Komen for the Cure. Each year, this conference brings together experts in cancer drug development from academic and clinical research, industry, federal…
On November 17, 2015, the eighth-annual Conference on Clinical Cancer Research was convened by Friends of Cancer Research and the Center for Health Policy at the Brookings Institution with the support of Susan G. Komen for the Cure. Each year, this conference brings together a diverse group of experts in cancer drug development from academic…
For the past five years, Prevision Policy has hosted a high-level conference focused on FDA and CMS policy issues. This year, Friends joined as co-hosts for the 2015 Biopharma Congress. The event previewed key issues for biopharma coming up in 2016 and had an audience comprised of regulators, industry, patient advocacy groups and congressional staff, as…
Each year, Friends of Cancer Research (Friends) and the Engelberg Center for Health Care Reform at Brookings convene the Conference on Clinical Cancer Research. This annual conference is the culmination of year spent in collaborative meetings and working groups, writing pre-conference reports and developing patient-driven solutions to the most pressing issues in cancer care. The conference…
Overview Each year, Friends of Cancer Research (Friends) and the Engelberg Center for Health Care Reform at Brookings convene the Conference on Clinical Cancer Research to address critical issues in the development of new drugs. This annual conference brings together leaders from federal health and regulatory agencies, academic research centers, patient advocacy organizations and the private sector to propose…
